Michael Alfieri

Nessuna posizione attualmente

59 anni

Health Technology

Consumer Services

Profilo

Michael Alfieri worked as a Controller at Merrimack Pharmaceuticals from 2014 to 2017.
He then worked as a Controller & Executive Director-Finance at Anika Therapeutics from 2010 to 2014.
In 2017, he worked as a Vice President-Finance at Radius Health.
In 2018, he worked as VP-Finance, Chief Financial & Accounting Officer at Genocea Biosciences.
Mr. Alfieri received his undergraduate and graduate degrees from Bentley University.

Precedenti posizioni note di Michael Alfieri

Società	Posizione	Fine
RADIUS HEALTH, INC.	Corporate Officer/Principal	01/05/2018
MERRIMACK PHARMACEUTICALS, INC.	Comptroller/Controller/Auditor	01/01/2017
ANIKA THERAPEUTICS, INC.	Comptroller/Controller/Auditor	01/07/2014
GENOCEA BIOSCIENCES, INC.	Direttore Finanziario/CFO	05/03/2019

Vedi nel dettaglio l'esperienza di Michael Alfieri

Formazione di Michael Alfieri

Bentley University

Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Alfieri

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
ANIKA THERAPEUTICS, INC.	Health Technology
GENOCEA BIOSCIENCES, INC.	Health Technology
MERRIMACK PHARMACEUTICALS, INC.	Health Technology

Aziende private	1
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.	Health Technology